Evaluation of humoral immune response in adaptive immunity in ALS patients during disease progression

Journal of Neuroimmunology

Volumn 215, Issue 1-2, 2009, Pages 96-101

  Saleh, Islam A ^a   Zesiewicz, Theresa ^a   Xie, Yong ^a   Sullivan, Kelly L ^a   Miller, Amber M ^a   Kuzmin Nichols, Nicole ^b   Sanberg, Paul R ^a   Garbuzova Davis, Svitlana ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b Saneron CCEL Therapeutics Inc   (United States)

Author keywords

Amyotrophic lateral sclerosis; Circulating immune complexes; Humoral immune response; IgG; IgM

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADAPTIVE IMMUNITY; ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; EVALUATION; FEMALE; HUMAN; HUMORAL IMMUNITY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; MALE; PRIORITY JOURNAL;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANTIGEN-ANTIBODY COMPLEX; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNITY, INNATE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED;

EID: 70349858276     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2009.07.011     Document Type: Article

References (42)

1. Alexianu M.E., Kozovska M., and Appel S.H. Immune reactivity in a mouse model of familial ALS correlates with disease progression. Neurology 57 (2001) 1282-1289
2. Apostolski S., Nikolić J., Bugarski-Prokopljević C., Miletić V., Pavlović S., and Filipović S. Serum and CSF immunological findings in ALS. Acta Neurol. Scand. 83 (1991) 96-98
3. Appel S.H., Stockton-Appel V., Stewart S.S., and Kerman R.H. Amyotrophic lateral sclerosis. Associated clinical disorders and immunological evaluations. Arch. Neurol. 43 (1986) 234-238
4. Bartfeld H., Dham C., Donnenfeld H., Jashnani L., Carp R., Kascsak R., Vilcek J., Rapport M., and Wallenstein S. Immunological profile of amyotrophic lateral sclerosis patients and their cell-mediated immune responses to viral and CNS antigens. Clin. Exp. Immunol. 48 (1982) 137-146
5. Bartfeld H., Dham C., and Donnenfeld H. Immunoregulatory and activated T cells in amyotrophic lateral sclerosis patients. J. Neuroimmunol. 9 (1985) 131-137
6. Brooks B.R. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors. J. Neurol. Sci. 124 (1994) 96-107 Suppl
7. Brooks B.R., Miller R.G., Swash M., Munsat T.L., and World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 1 (2000) 293-299
8. Cedarbaum J.M., Stambler N., Malta E., Fuller C., Hilt D., Thurmond B., and Nakanishi A. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J. Neurol. Sci. 169 (1999) 13-21
9. Chia D., Barnett E.V., Yamagata J., Knutson D., Restivo C., and Furst D. Quantitation and characterization of soluble immune complexes precipitated from sera by polyethylene glycol (PEG). Clin. Exp. Immunol. 37 (1979) 399-407
10. Cleveland D.W., and Rothstein J.D. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat. Rev. Neurosci. 2 (2001) 806-819
11. Cooper K.M., and Moore M. Critical aspects of immune complex assays employing polyethylene glycol. J. Immunol. Methods 60 (1983) 289-302
12. Donnenfeld H., Kascsak R.J., and Bartfeld H. Deposits of IgG and C3 in the spinal cord and motor cortex of ALS patients. J. Neuroimmunol. 6 (1984) 51-57
13. Edwards J.C., Cambridge G., and Abrahams V.M. Do self-perpetuating B lymphocytes drive human autoimmune disease?. Immunology 97 (1999) 188-196
14. Engelhardt J.L., and Appel S.H. IgG reactivity in the spinal cord and motor cortex in amyotrophic lateral sclerosis. Arch. Neurol. 47 (1990) 1210-1216
15. Engelhardt J.I., Tajti J., and Appel S.H. Lymphocytic infiltrates in the spinal cord in amyotrophic lateral sclerosis. Arch. Neurol. 50 (1993) 30-36
16. Engelhardt J.I., Soós J., Obál I., Vigh L., and Siklós L. Subcellular localization of IgG from the sera of ALS patients in the nervous system. Acta Neurol. Scand. 112 (2005) 126-133
17. Fiszman M.L., Borodinsky L.N., Ricart K.C., Sanz O.P., and Sica R.E. Cu/Zn superoxide dismutase activity at different ages in sporadic amyotrophic lateral sclerosis. J. Neurol. Sci. 162 (1999) 34-37
18. Goodall E.F., and Morrison K.E. Amyotrophic lateral sclerosis motor neuron disease: proposed mechanisms and pathways to treatment. Expert. Rev. Mol. Med. 8 (2006) 1-22
19. Haverkamp L.J., Appel V., and Appel S.H. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain 118 (1995) 707-719
20. Holmøy T. T cells in amyotrophic lateral sclerosis. Eur. J. Neurol. 15 (2008) 360-366
21. Ingham K.C. Precipitation of proteins with polyethylene glycol. Methods Enzymol. 182 (1990) 301-306
22. Kávai M., Lukács K., Sonkoly I., Pálóczi K., and Szegedi G. Circulating immune complexes and monocyte Fc function in autoimmune diseases. Ann. Rheum. Dis. 38 (1979) 79-83
23. Kawamata T., Akiyama H., Yamada T., and McGeer P.L. Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am. J. Pathol. 140 (1992) 691-707
24. Latifynia A., Vojgani M., Abofazeli T., and Jafarieh H. Circulating immune complex during Ramadan. J. Ayub. Med. Coll. Abbottabad. 19 (2007) 15-18
25. Lederer C.W., and Santama N. Amyotrophic lateral sclerosis - the tools of the trait. Biotechnol. J. 2 (2007) 608-621
26. Manger B.J., Krapf F.E., Gramatzki M., Nüsslein H.G., Burmester G.R., Krauledat P.B., and Kalden J.R. IgE-containing circulating immune complexes in Churg-Strauss vasculitis. Scand. J. Immunol. 21 (1985) 369-373
27. McGeer P.L., and McGeer E.G. Inflammatory processes in amyotrophic lateral sclerosis. Muscle Nerve 26 (2002) 459-470
28. Noronha A.B., Antel J.P., Roos R.P., and Medof M.E. Circulating immune complexes in neurologic disease. Neurology 31 (1981) 1402-1407
29. Oldstone M.B., Wilson C.B., Perrin L.H., and Norris Jr. F.H. Evidence for immune-complex formation in patients with amyotrophic lateral sclerosis. Lancet 2 (1976) 169-172
30. Pramatarova A., Figlewicz D.A., Krizus A., Han F.Y., Ceballos-Picot I., Nicole A., Dib M., Meininger V., Brown R.H., and Rouleau G.A. Identification of new mutations in the Cu/Zn superoxide dismutase gene of patients with familial amyotrophic lateral sclerosis. Am. J. Hum. Genet. 56 (1995) 592-596
31. Provinciali L., Laurenzi M.A., Vesprini L., Giovagnoli A.R., Bartocci C., Montroni M., Bagnarelli P., Clementi M., and Varaldo P.E. Immunity assessment in the early stages of amyotrophic lateral sclerosis: a study of virus antibodies and lymphocyte subsets. Acta Neurol. Scand. 78 (1988) 449-454
32. Rahman A., and Isenberg D.A. Systemic lupus erythematosus. N. Engl. J. Med. 358 (2008) 929-939
33. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J.P., Deng H.X., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362 (1993) 59-62
34. Rowland L.P., and Shneider N.A. Amyotrophic lateral sclerosis. New Engl. J. Med. 344 (2001) 1688-1700
35. Soltis R.D., and Hasz D.E. The effect of serum immunoglobulin concentration on immune complex detection by polyethylene glycol. J. Immunol. Methods 57 (1983) 275-282
36. Tachovsky T.G., Lisak R.P., Koprowski H., Theofilopoulos A.N., and Dixon F.J. Circulating immune complexes in multiple sclerosis and other neurological diseases. Lancet 2 (1976) 997-999
37. Troost D., Van Den Oord J.J., and Vianney de Jong J.M. Immunohistochemical characterization of the inflammatory infiltrate in amyotrophic lateral sclerosis. J. Neuropathol. Appl. Neurobiol. 16 (1990) 410-410
38. Tsai J.F., Tsai J.H., Chang W.Y., and Ton T.C. Elevation of circulating immune complexes and its relationship to alpha-fetoprotein levels in patients with hepatitis B surface antigen-positive hepatocellular carcinoma. Cancer Invest. 9 (1991) 137-143
39. van der Giessen M., and The T.H. Characterization of the soluble immune complexes that are detected by three different techniques. Clin. Immunol. Immunopathol. 38 (1986) 244-255
40. Westarp M.E., Bartmann P., and Kornhuber H.H. Immunoglobulin-G isotype changes in human sporadic amyotrophic lateral sclerosis (ALS). Neurosci. Lett. 173 (1994) 124-126
41. Zhang R., Gascon R., Miller R.G., Gelinas D.F., Mass J., Hadlock K., Jin X., Reis J., Narvaez A., and McGrath M.S. Evidence for systemic immune system alterations in sporadic amyotrophic lateral sclerosis (sALS). J. Neuroimmunol. 159 (2005) 215-224
42. Zhang R., Gascon R., Miller R.G., Gelinas D.F., Mass J., Lancero M., Narvaez A., and McGrath M.S. MCP-1 chemokine receptor CCR2 is decreased on circulating monocytes in sporadic amyotrophic lateral sclerosis (sALS). J. Neuroimmunol. 179 (2006) 87-93